Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...
Super-enhancers (SEs) are large clusters of transcriptional regulatory elements that drive oncogene expression, maintain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results